2016 INDUCTEE Mark Wainberg, PhD Global Health, Public Health, Health Promotion & Advocacy, Patient Care, Infectious Disease, Allergy & Immunity

Mark Wainberg inducted into the Canadian Medical Hall of Fame

Hamilton, Ontario

The annual Mark Wainberg Lectureship was created at the Canadian Association of HIV Research’s annual conference

While president of the International AIDS Society, Dr. Wainberg organized and co-chaired the first International Conference on HIV Microbicides in Washington DC

Under Dr. Wainberg’s leadership, the XIIIth International Conference on AIDS took place in Durban, South Africa

Dr. Wainberg established the Journal of the International AIDS Society

He created the journal, in part, to feature both AIDS research in lower and middle income countries as well as the research authored by scientists in those countries.

For two years, Dr. Wainberg served as Chairman of the Working Group of AIDS Research and Related Subjects for the National Advisory Committee on AIDS

He later became President of the Canadian Association for HIV Research.

In collaboration with BioChem Pharma Inc., Dr. Mark Wainberg and his team identified 3TC as an anti-viral drug

The discovery gave hope to many at a time when few options existed for HIV treatment.

The US Centers for Disease Control and Prevention published a report describing several cases of rare lung infection in five young, previously health, gay men in LA

This document is now recognized as the first official reporting of the AIDS epidemic.

Returned from post-doctoral studies in Israel to take up a position at McGill University and as an independent investigator at the Lady David Institute of the Jewish General Hospital in Montreal